146 related articles for article (PubMed ID: 36310109)
1. SAR exploration of the non-imidazole histamine H
Wágner G; Mocking TAM; Ma X; Slynko I; Da Costa Pereira D; Breeuwer R; Rood NJN; van der Horst C; Vischer HF; de Graaf C; de Esch IJP; Wijtmans M; Leurs R
Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200451. PubMed ID: 36310109
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor.
Shi Y; Sheng R; Zhong T; Xu Y; Chen X; Yang D; Sun Y; Yang F; Hu Y; Zhou N
PLoS One; 2012; 7(8):e42185. PubMed ID: 22870296
[TBL] [Abstract][Full Text] [Related]
3. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
[TBL] [Abstract][Full Text] [Related]
4. N (α)-Methylated phenylhistamines exhibit affinity to the hH(4)R-a pharmacological and molecular modelling study.
Wittmann HJ; Elz S; Seifert R; Straber A
Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):287-99. PubMed ID: 21800095
[TBL] [Abstract][Full Text] [Related]
5. Covalent Inhibition of the Histamine H
Wágner G; Mocking TAM; Kooistra AJ; Slynko I; Ábrányi-Balogh P; Keserű GM; Wijtmans M; Vischer HF; de Esch IJP; Leurs R
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835873
[TBL] [Abstract][Full Text] [Related]
6. The evolution of histamine H₃ antagonists/inverse agonists.
Lebois EP; Jones CK; Lindsley CW
Curr Top Med Chem; 2011; 11(6):648-60. PubMed ID: 21261594
[TBL] [Abstract][Full Text] [Related]
7. Identification of the antiarrhythmic drugs amiodarone and lorcainide as potent H3 histamine receptor inverse agonists.
Del Tredici AL; Ma JN; Piu F; Burstein ES
J Pharmacol Exp Ther; 2014 Jan; 348(1):116-24. PubMed ID: 24204014
[TBL] [Abstract][Full Text] [Related]
8. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA
Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
10. 1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H
Shinde AK; Badange RK; Reballi V; Achanta PK; Bojja K; Manchineella S; Rao Muddana N; Subramanian R; Choudary Palacharla R; Benade V; Jayarajan P; Thentu JB; Lingavarapu BB; Yarra S; Kagita N; Rao Doguparthi M; Mohammed AR; Nirogi R
ChemMedChem; 2022 Feb; 17(3):e202100583. PubMed ID: 34761873
[TBL] [Abstract][Full Text] [Related]
11. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.
Gbahou F; Davenas E; Morisset S; Arrang JM
J Pharmacol Exp Ther; 2010 Sep; 334(3):945-54. PubMed ID: 20530654
[TBL] [Abstract][Full Text] [Related]
12. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
13. Histamine H3 receptor as a drug discovery target.
Berlin M; Boyce CW; Ruiz Mde L
J Med Chem; 2011 Jan; 54(1):26-53. PubMed ID: 21062081
[No Abstract] [Full Text] [Related]
14. Pharmacological characterization of seven human histamine H
Gao M; Dekker ME; Leurs R; Vischer HF
Eur J Pharmacol; 2024 Apr; 968():176450. PubMed ID: 38387718
[TBL] [Abstract][Full Text] [Related]
15. A Photoswitchable Agonist for the Histamine H
Hauwert NJ; Mocking TAM; Da Costa Pereira D; Lion K; Huppelschoten Y; Vischer HF; De Esch IJP; Wijtmans M; Leurs R
Angew Chem Int Ed Engl; 2019 Mar; 58(14):4531-4535. PubMed ID: 30735597
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Steroid-Based Histamine H
Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Barabás J; Béni Z; Varga B; Balázs O; Román V; Fodor L; Szikra J; Vastag M; Lévay G; Schmidt É; Lendvai B; Greiner I; Kiss B; Némethy Z; Mahó S
J Med Chem; 2024 Mar; 67(5):3643-3667. PubMed ID: 38393759
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptors.
Sors A; Panayi F; Bert L; Favale D; Nosjean O; Audinot V; Arrang JM; Buisson B; Steidl E; Delbos JM; Huhtala T; Kontkanen O; Chollet AM; Casara P; Lestage P
Eur J Pharmacol; 2017 May; 803():11-23. PubMed ID: 28336400
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
Ishikawa M; Watanabe T; Kudo T; Yokoyama F; Yamauchi M; Kato K; Kakui N; Sato Y
J Med Chem; 2010 Sep; 53(17):6445-56. PubMed ID: 20690643
[TBL] [Abstract][Full Text] [Related]
20. 4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H
Wágner G; Mocking TAM; Arimont M; Provensi G; Rani B; Silva-Marques B; Latacz G; Da Costa Pereira D; Karatzidou C; Vischer HF; Wijtmans M; Kieć-Kononowicz K; de Esch IJP; Leurs R
J Med Chem; 2019 Dec; 62(23):10848-10866. PubMed ID: 31675226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
